Kurt Oreshack's most recent trade in Maravai LifeSciences Holdings Inc - Ordinary Shares - Class A was a trade of 295,858 Class A Common Stock done . Disclosure was reported to the exchange on March 17, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Maravai LifeSciences Holdi... | Kurt Oreshack | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2025 | 295,858 | 456,869 | - | - | Class A Common Stock | |
| Maravai LifeSciences Holdi... | Kurt Oreshack | General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.64 per share. | 17 Mar 2025 | 4,579 | 161,011 | - | 2.6 | 12,089 | Class A Common Stock |
| Maravai LifeSciences Holdi... | Kurt Oreshack | General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.10 per share. | 18 Feb 2025 | 2,028 | 165,590 | - | 4.1 | 8,315 | Class A Common Stock |
| Maravai LifeSciences Holdi... | Kurt Oreshack | General Counsel | Sale of securities on an exchange or to another person at price $ 5.03 per share. | 31 Jan 2025 | 25,000 | 167,618 | - | 5.0 | 125,750 | Class A Common Stock |
| Maravai LifeSciences Holdi... | Kurt Oreshack | General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.56 per share. | 15 Jan 2025 | 31,438 | 192,618 | - | 4.6 | 143,357 | Class A Common Stock |
| Maravai LifeSciences Holdi... | Kurt Oreshack | General Counsel | Grant, award, or other acquisition of securities at price $ 5.70 per share. | 31 Oct 2024 | 366 | 224,056 | - | 5.7 | 2,086 | Class A Common Stock |
| Maravai LifeSciences Holdi... | Kurt Oreshack | General Counsel | Grant, award, or other acquisition of securities at price $ 5.70 per share. | 30 Apr 2024 | 341 | 223,690 | - | 5.7 | 1,944 | Class A Common Stock |
| Maravai LifeSciences Holdi... | Kurt Oreshack | General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.70 per share. | 15 Mar 2024 | 4,551 | 223,349 | - | 7.7 | 35,043 | Class A Common Stock |
| Maravai LifeSciences Holdi... | Oreshack Kurt | General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.48 per share. | 15 Feb 2024 | 2,322 | 227,900 | - | 5.5 | 12,725 | Class A Common Stock |
| Maravai LifeSciences Holdi... | Oreshack Kurt | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2024 | 166,852 | 230,222 | - | - | Class A Common Stock | |
| Maravai LifeSciences Holdi... | Kurt Oreshack | General Counsel | Grant, award, or other acquisition of securities at price $ 11.72 per share. | 28 Apr 2023 | 1,014 | 63,370 | - | 11.7 | 11,884 | Class A Common Stock |
| Maravai LifeSciences Holdi... | Kurt Oreshack | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2023 | 76,500 | 76,500 | - | - | Employee Stock Options (Right to Buy) | |
| Maravai LifeSciences Holdi... | Kurt Oreshack | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2023 | 38,386 | 62,356 | - | - | Class A Common Stock | |
| Maravai LifeSciences Holdi... | Kurt Oreshack | General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.23 per share. | 15 Feb 2023 | 2,312 | 23,970 | - | 15.2 | 35,212 | Class A Common Stock |
| Maravai LifeSciences Holdi... | Kurt Oreshack | General Counsel | Grant, award, or other acquisition of securities at price $ 14.11 per share. | 31 Oct 2022 | 351 | 26,282 | - | 14.1 | 4,953 | Class A Common Stock |
| Maravai LifeSciences Holdi... | Kurt Oreshack | General Counsel | Grant, award, or other acquisition of securities at price $ 22.95 per share. | 29 Apr 2022 | 394 | 25,931 | - | 22.9 | 9,042 | Class A Common Stock |
| Maravai LifeSciences Holdi... | Kurt Oreshack | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2022 | 31,500 | 31,500 | - | - | Employee Stock Option (Right to Buy) | |
| Maravai LifeSciences Holdi... | Kurt Oreshack | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2022 | 17,000 | 25,537 | - | - | Class A Common Stock | |
| Maravai LifeSciences Holdi... | Kurt Oreshack | General Counsel | Grant, award, or other acquisition of securities at price $ 22.95 per share. | 25 Jan 2022 | 542 | 8,537 | - | 23.0 | 12,439 | Class A Common Stock |
| Maravai LifeSciences Holdi... | Kurt Oreshack | General Counsel | Grant, award, or other acquisition of securities at price $ 22.95 per share. | 25 Jan 2022 | 495 | 7,995 | - | 22.9 | 11,360 | Class A Common Stock |
| Maravai LifeSciences Holdi... | Kurt Oreshack | General Counsel | Purchase of securities on an exchange or from another person at price $ 27.00 per share. | 24 Nov 2020 | 7,500 | 7,500 | - | 27 | 202,500 | Class A Common Stock |
| Maravai LifeSciences Holdi... | Kurt Oreshack | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2020 | 40,000 | 40,000 | - | - | Employee Stock Options (Right to Buy) |